Dublin, Feb. 14, 2017 -- Research and Markets has announced the addition of the "Cholera Forecast for selected Asian Markets 2017-2027" report to their offering.
Cholera is a bacterial disease caused by infection from Vibrio cholerae species (O1, O139), usually spread through contaminated water. Cholera causes severe diarrhoea and dehydration. Left untreated, cholera can be fatal in a matter of hours, even in previously healthy people.
This report provides the current incidence population for Cholera for Selected Asian Markets (Cambodia, Indonesia, Lao PDR, and Vietnam) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms of Cholera have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Risk factors for contracting cholera relate mostly to contaminated water and sanitation. The disease shows marked seasonality in developing nations, and outbreaks can occur during natural disasters (tsunamis) and complex emergencies (generally affecting the water supply / sanitation infrastructure).
This report is built using data and information sourced from the proprietary patient segmentation database. To generate accurate patient population estimates, the database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Key Topics Covered:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography
6. Disease Prognosis & Clinical Course
7. Methodology for quantification of patient numbers
8. Top-line estimated incidence for Cholera
9. Cholera in Vietnam
10. Abbreviations used in the report
11. Patient-Based Offering
12. Online Pricing Data and Platforms
13. References
14. Appendix
For more information about this report visit http://www.researchandmarkets.com/research/vh5jzd/cholera_forecast
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs


Bill Ackman Eyes New Fund to Bet Against Market Complacency
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home 



